$100 Billion Tobacco Giant Altria (NYSE:MO) Just Bet Big on This Cannabis Stock

The cannabis industry has been hit hard in recent months, with popular marijuana-based ETFs down 50% or more. Yet recent actions from $100 billion tobacco behemoth Altria Group (NYSE:MO) could signal a bottom. On November 20, Altria purchased four million shares of Cronos Group (TSX:CRON)(NASDAQ:CRON), adding to its existing position in the company. Notably, the purchases follow a steep 70%…

Read More

Will Cronos (TSX:CRON) Stock Move Higher After a 25% Decline Last Week?

Shares of leading cannabis company Cronos Group (TSX:CRON)(NASDAQ:CRON) fell over 25% in the last week. Why did Cronos Group investors lose a quarter of their market value in the week ended on November 15, 2019? Cronos Group announced its third-quarter results on November 12 and reported sales of $12.7 million — 238% higher compared to sales of $3.76 million in…

Read More

Cannabis Investors: 3 Big Changes Coming Soon to Cronos Group’s (TSX:CRON)

Cannabis firm Cronos Group (TSX:CRON)(NASDAQ:CRON) reported its third-quarter financial results on Wednesday this week and management has announced some significant changes to the business. Investors need be aware of the following fundamental changes to the company’s future operations and financial results presentations going forward. Here’s what you need to know. Big change in applicable accounting standards First, the company will…

Read More

The U.S. Market Could Send These Cannabis Stocks Soaring in 2020

Canada’s cannabis market is going crazy. A new report suggests that spending, which totaled $570 million in 2018, will grow by at least 40% per year, surpassing $5 billion by 2024. It’s not often that a multi-billion-dollar market appears practically overnight, but this is one of those rare opportunities. “Canada is the largest country in the world to legalize cannabis,…

Read More

5 Important Takeaways From Cronos Group’s (TSX:CRON) Latest Quarterly Earnings

A sequential quarterly net revenue growth of 24% and a 214% jump in quarterly net earnings to $788 million could top the highlights for Cronos Group’s (TSX:CRON)(NASDAQ:CRON) latest financial report delivered early on Tuesday, but there was a lot to chew in the company’s latest quarterly results. Let’s just quickly get down to it. Revenue growth was aided Cronos reported…

Read More

Better Cannabis Buy: Cronos (TSX:CRON) vs. Tilray (NASDAQ:TLRY)

Cannabis investors continue to experience a steep decline in the value of their investments. However, several cannabis stocks are trading close to their 52-week lows and might gain in market value as we head into 2020. Here, we look at two stocks that have corrected significantly in the last year. The stocks are Cronos (TSX:CRON)(NASDAQ:CRON) and Tilray (NASDAQ:TLRY). Cronos went…

Read More

TFSA Investors: This Cannabis Company Could Transform Your Portfolio

If you have a TFSA, high-growth stocks have a ton of appeal, as you’ll pay zero taxes on your gains. Even if your portfolio triples in value, your money will be shielded from the tax collector. There are few higher growth markets than cannabis. Most analysts agree that the market could surpass $100 billion in value by 2030. Stifel Financial…

Read More

Top Weed Stocks for 2020

It’s been a horrible year for legal marijuana stocks across the board. Collectively, the top three players have shed billions in market value and currently trading at less than half their price at the start of the year. Some smaller players are indeed on the verge of bankruptcy.  The outlook is dire and the industry is struggling to find its…

Read More

Why Hexo (TSX:HEXO) Stock Dropped 25% on Thursday and Why it Could Reverse Course Quickly

HEXO (TSX:HEXO)(NYSE:HEXO) stock is in a free fall. From April to September, shares fell by 50%. Then, on October 10, the stock dropped 25% in a single trading session. So far, the declines are continuing. Once a $3 billion company, HEXO is now worth just $900 million. Investors and analysts are fleeing the stock en masse. What happened to this…

Read More

2 Cannabis Stocks That Could Land a Game-Changing Partner in 2020

Last year, nearly every cannabis company was racing to find a big-time partner. Cronos Group, for example, secured a $1.8 billion deal with tobacco giant Altria Group. Cronos stock ran more than 100% on the news, rising to a peak market cap of $20 billion. Canopy Growth, meanwhile, locked down a $4 billion capital infusion from Constellation Brands, causing shares…

Read More